⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2454966 | 0.84 | — | — | |
| SCHEMBL2590771 | 0.65 | — | — | |
| SCHEMBL23866558 | 0.56 | — | — | |
| SCHEMBL256748 | 0.56 | — | — | |
| SCHEMBL7050307 | 0.50 | — | — | |
| SCHEMBL28393922 | 0.50 | — | — | |
| Cyclohexane SCHEMBL27713852 | 0.50 | — | — | |
| Cyclohexane SCHEMBL27992338 | 0.50 | — | — | |
| Cyclopropane SCHEMBL6702170 | 0.50 | — | — | |
| SCHEMBL28541358 | 0.47 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4628077-A2 | LONG-ACTING SPIRO-ISOXAZOLINE FORMULATIONS | Zoetis Services LLC (US) | 2025-10-08 | — | — | EP | claimed |
| US-11524968-B2 | Heterocyclic compound as a protein kinase inhibitor | HK INNO.N CORPORATION (KR) | 2022-12-13 | — | — | US | claimed |
| US-20220016113-A1 | ?2-ADRENOCEPTOR SUBTYPE C (ALPHA-2C) ANTAGONISTS FOR THE TREATMENT OF SLEEP APNEA | BAYER AKTIENGESELLSCHAFT (DE) | 2022-01-20 | — | — | US | claimed |
| EP-3883933-A1 | a2-ADRENOCEPTOR SUBTYPE C (ALPHA-2C) ANTAGONISTS FOR THE TREATMENT OF SLEEP APNEA | Bayer Aktiengesellschaft (DE) | 2021-09-29 | — | — | EP | claimed |
| US-20200230136-A1 | SELECTIVE ADRENORECEPTOR ALPHA2C RECEPTOR ANTAGONISTS ALONE, OR IN COMBINATION WITH CHYMASE INHIBITORS FOR USE IN THE TREATMENT AND/OR PROPHYLAXIS OF PERIPHERAL ARTERY DISEASES (PAD) | BAYER AKTIENGESELLSCHAFT (DE) | 2020-07-23 | — | — | US | claimed |
| EP-3615031-A1 | SELECTIVE ADRENORECEPTOR ALPHA2C RECEPTOR ANTAGONISTS ALONE, OR IN COMBINATION WITH CHYMASE INHIBITORS FOR USE IN THE TREATMENT AND/OR PROPHYLAXIS OF PERIPHERAL ARTERY DISEASES (PAD) | Bayer Aktiengesellschaft (DE) | 2020-03-04 | — | — | EP | claimed |
| WO-2018197333-A1 | SELECTIVE ADRENORECEPTOR ALPHA2C RECEPTOR ANTAGONISTS ALONE, OR IN COMBINATION WITH CHYMASE INHIBITORS FOR USE IN THE TREATMENT AND/OR PROPHYLAXIS OF PERIPHERAL ARTERY DISEASES (PAD) | BAYER AKTIENGESELLSCHAFT (DE) | 2018-11-01 | — | — | WO | claimed |
| EP-3083592-B1 | SUBSTITUTED PIPERIDINYL-TETRAHYDROQUINOLINES AND THEIR USE AS ALPHA-2C ADRENORECEPTOR ANTAGONISTS | Bayer Pharma AG (DE) | 2018-06-27 | — | — | EP | claimed |
| US-9944621-B2 | Substituted piperidinyl tetrahydroquinolines | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2018-04-17 | — | — | US | claimed |
| US-9624198-B2 | Substituted piperidinyltetrahydroquinolines | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2017-04-18 | — | — | US | claimed |
| EP-3083592-A2 | SUBSTITUTED PIPERIDINYL-TETRAHYDROQUINOLINES AND THEIR USE AS ALPHA-2C ADRENORECEPTOR ANTAGONISTS | Bayer Pharma Aktiengesellschaft (DE) | 2016-10-26 | — | — | EP | claimed |
| EP-3083593-A1 | SUBSTITUTED PIPERIDINYL-TETRAHYDROQUINOLINES | Bayer Pharma Aktiengesellschaft (DE) | 2016-10-26 | — | — | EP | claimed |
| US-20160304491-A1 | SUBSTITUTED PIPERIDINYLTETRAHYDROQUINOLINES | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2016-10-20 | — | — | US | claimed |
| US-20160235720-A1 | Long-Acting Spiro-Isoxazoline Formulations | ZOETIS SERVICES LLC | 2016-08-18 | — | — | US | claimed |
| EP-3052080-A1 | LONG-ACTING SPIRO-ISOXAZOLINE FORMULATIONS | Zoetis Services LLC (US) | 2016-08-10 | — | — | EP | claimed |
| EP-2999339-A1 | LONG-ACTING SPIRO-ISOXAZOLINE ANTIPARASITIC COMPOSITIONS | Zoetis Services LLC (US) | 2016-03-30 | — | — | EP | claimed |
| US-20160081986-A1 | LONG-ACTING SPIRO-ISOXAZOLINE ANTIPARASITIC COMPOSITIONS | ZOETIS SERVICES LLC (US) | 2016-03-24 | — | — | US | claimed |
| WO-2015091417-A1 | SUBSTITUTED PIPERIDINYL-TETRAHYDROQUINOLINES | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2015-06-25 | — | — | WO | claimed |
| WO-2015091414-A2 | SUBSTITUTED PIPERIDINYL-TETRAHYDROQUINOLINES | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2015-06-25 | — | — | WO | claimed |
| WO-2015048371-A1 | LONG-ACTING SPIRO-ISOXAZOLINE FORMULATIONS | ZOETIS LLC (US) | 2015-04-02 | — | — | WO | claimed |